α受体阻滞剂用于缓解前列腺增生（BPH），最早报道于1976年。近年来，因其疗效确切而被广泛的应用。然而，这类药物的临床评价和应用仍存在许多问题。本文就．此内容评述如下。1α受体阻滞剂的选择多年来，人们曾认为选择型α1受体阻滞剂的效果优于α1和α2结合型阻滞剂，原因 Alpha blockers used to relieve benign prostatic hyperplasia (BPH), first reported in 1976. In recent years, because of its exact effect has been widely used. However, there are still many problems in the clinical evaluation and application of these drugs. This article is. The content is as follows. Choice of 1Î ± Receptor Blockers Over the years, the selective α1 blockers have been considered superior to α1 and α2 blockers for many reasons